This added weight strains the heart, disrupts metabolism, causes digestive issues, and can make breathing more difficult
Oral GLP-1 Options For patients who are super responders or uncomfortable with injections, oral GLP-1 options may be available
If you trust your patient to manage their insulin, Jervey said, you can trust them to pick up one of these new medications with the proper education. Learn more about research for new type 1 diabetes treatments:
GLP-1 also induces satiety, resulting in lower voluntary caloric intake
For the SURPASS-CVOT emulation (tirzepatide vs dulaglutide), the hazard ratio for MACE was 0.83 (95% CI, 0.691.01) compared with 0.92 (95% CI, 0.831.01) in the trial, satisfying all concordance criteria